Lotus Pharmaceuticals, Inc. (LTUS)

Market Cap	9.52M -78.4%
Revenue (ttm)	71.39M +4.3%
Net Income	1.72M -91.6%
EPS	0.06 -92.0%
Shares Out	2.64B
PE Ratio	0.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,900
Average Volume	18,174
Open	0.0036
Previous Close	0.0036
Day's Range	0.0036 - 0.0036
52-Week Range	0.0025 - 0.0111
Beta	-1.80
RSI	47.20
Earnings Date	n/a

About Lotus Pharmaceuticals

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People’s Republic of China. The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.

• Industry: Shell Companies
• Sector: Financials
• CEO: Zhong Yi Liu
• Employees: 533
• Stock Exchange: OTCMKTS
• Ticker Symbol: LTUS